Inflammatory diseases span nearly every organ system in the body, from joints and skin to the brain and blood vessels. Some involve the immune system attacking healthy tissue. Others stem from chronic, low-grade inflammation that builds over years. While the triggers differ, they share a common thread: the body’s inflammatory response, normally a short-term defense against injury or infection, becomes persistent and starts causing damage instead of healing it.
Rheumatoid Arthritis
Rheumatoid arthritis (RA) is the most common form of inflammatory joint disease, affecting between 0.5% and 1% of the global population. It’s an autoimmune condition, meaning the immune system mistakenly targets the body’s own joint tissue. In someone who is genetically susceptible, environmental factors like smoking or certain infections can trigger a system-wide immune response that eventually zeroes in on the joints. Immune cells flood the joint lining, releasing signaling molecules that cause swelling, pain, and stiffness, particularly in the small joints of the hands and feet.
Without early treatment, the ongoing inflammation erodes cartilage and bone. RA is typically identified by a combination of factors: which joints are affected, how long symptoms have lasted, blood markers of inflammation, and the presence of specific antibodies. The goal of modern treatment is to suppress the overactive immune response early, before permanent joint damage sets in.
Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) includes two major conditions: Crohn’s disease and ulcerative colitis. Both cause diarrhea, abdominal pain, and fatigue, but they affect the gut in distinct ways.
Ulcerative colitis is confined to the large intestine. It typically starts in the rectum and spreads upward in a continuous stretch, with inflammation limited to the innermost lining of the colon. This is why lower abdominal cramps and rectal bleeding are its hallmark symptoms.
Crohn’s disease can strike anywhere along the digestive tract, from the mouth to the anus. Unlike ulcerative colitis, it often skips areas, leaving patches of healthy tissue between inflamed sections. The inflammation in Crohn’s can also penetrate deeper through the intestinal wall, which creates the risk of complications like narrowing of the intestine, tunnels between tissues (fistulas), and pockets of infection. These structural differences are a major reason why Crohn’s disease and ulcerative colitis require different management strategies, even though they look similar on the surface.
Psoriasis and Related Conditions
Psoriasis is far more than a skin problem. The red, scaly plaques on the surface are a visible sign of chronic inflammation happening throughout the body. Up to 30% of people with psoriasis go on to develop psoriatic arthritis, which causes joint pain and swelling similar to RA.
The systemic nature of psoriasis becomes clear when you look at its connections to other diseases. People with psoriasis face roughly six times the risk of developing rheumatoid arthritis and nearly five times the risk of vitiligo compared to the general population. They’re also more likely to develop alopecia areata (an autoimmune form of hair loss), inflammatory bowel disease, autoimmune thyroid disease, and cardiovascular problems. These overlapping risks exist because psoriasis, at its core, is a disease of immune dysregulation that affects the whole body, not just the skin.
Atherosclerosis and Heart Disease
Heart disease isn’t just about cholesterol buildup. Inflammation plays a central role in the formation and rupture of arterial plaques. The process begins when immune cells migrate into the walls of blood vessels, triggering a local inflammatory response. These cells release signaling molecules, particularly one called IL-6, that recruit even more immune cells and generate oxidative stress. Over time, this cycle builds fatty, inflamed plaques that narrow arteries and can eventually rupture, causing heart attacks or strokes.
This is one reason doctors sometimes measure C-reactive protein (CRP), a blood marker of inflammation, alongside cholesterol. A high-sensitivity CRP level of 2.0 mg/L or above is associated with a higher risk of heart disease. The recognition that inflammation drives cardiovascular damage has reshaped how researchers think about prevention and treatment, placing diet, exercise, and inflammation-targeting therapies alongside traditional cholesterol management.
Asthma
Asthma is a chronic inflammatory disease of the airways. In most people with asthma, the inflammation is driven by an overactive branch of the immune system that produces signaling molecules responsible for airway swelling, excess mucus production, and tightening of the muscles around the airways. This isn’t a one-time reaction. The immune system creates long-lived memory cells in the lungs that can rapidly reactivate when exposed to allergens, cold air, exercise, or other triggers.
Over time, this chronic activation remodels the airway walls themselves, thickening them and plugging them with mucus. In severe asthma, this remodeling becomes a major contributor to permanent airflow obstruction, which is why controlling the underlying inflammation early and consistently matters more than just treating symptoms when they flare.
Neuroinflammation in Alzheimer’s Disease
The brain has its own immune cells, called microglia, that normally clear debris and protect neurons. In Alzheimer’s disease, these cells become chronically activated and turn harmful. Overactive microglia strip away synapses (the connections between brain cells) through a process that involves tagging them with complement proteins, essentially marking healthy synapses for destruction the same way the immune system marks bacteria.
Activated microglia also worsen the buildup of tau, a protein that tangles inside neurons and kills them. They release inflammatory molecules that injure neurons directly, and they can push neighboring support cells called astrocytes into a toxic state that causes further neuronal death. This inflammatory cascade helps explain why Alzheimer’s progresses even after the initial protein deposits form: the brain’s own immune response accelerates the damage.
How These Diseases Are Connected
One striking pattern across inflammatory diseases is how often they cluster together. Someone with psoriasis is more likely to develop IBD. People with RA have higher rates of cardiovascular disease. Chronic inflammation in one system rarely stays isolated. The signaling molecules that drive joint inflammation, for instance, circulate through the bloodstream and can promote plaque formation in arteries, insulin resistance, and even changes in the brain.
Blood tests for inflammation reflect this. CRP levels of 8 mg/L or higher signal significant systemic inflammation, regardless of where it originates. Another common test, the erythrocyte sedimentation rate (ESR), measures how quickly red blood cells settle in a tube, with faster settling indicating more inflammation. Neither test points to a specific disease, but both help gauge how active inflammation is across the body.
Reducing Inflammation Through Diet
Diet is one of the most practical levers for managing chronic inflammation. The modern Western diet has shifted dramatically toward omega-6 fatty acids (found in vegetable oils, processed foods, and grain-fed meat) and away from omega-3 fatty acids. Historically, humans consumed these fats in roughly equal proportions. Today, the ratio in a typical American diet ranges from 15-to-1 to 25-to-1 in favor of omega-6. This imbalance promotes sustained inflammatory signaling throughout the body.
Omega-3 fatty acids, found in fatty fish like salmon, as well as walnuts and flax seeds, help counteract this. They reduce the concentration of inflammatory signaling molecules at the arterial wall where plaques form, and they’re associated with lower rates of both heart disease and death from heart disease. A 100-gram serving of pink salmon provides about 1,000 milligrams of the two most active omega-3s combined. Walnuts are the richest plant source, with over 9,000 milligrams of the plant-based omega-3 per 100 grams.
How Inflammatory Diseases Are Treated
Treatment for inflammatory diseases has been transformed by biologic therapies, which are drugs designed to block specific molecules in the inflammatory cascade. The first wave of biologics targeted a signaling molecule called TNF-alpha, one of the earliest and most powerful drivers of inflammation. The first of these drugs was approved in 1998 for rheumatoid arthritis, and the class has since expanded to treat psoriasis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis.
Newer biologics target other molecules further along the inflammatory chain, offering options for people who don’t respond to TNF-alpha blockers. For asthma, biologics that block specific immune signaling molecules responsible for airway inflammation have given people with severe disease a way to reduce flares and, in some cases, taper off oral steroids. The principle across all these conditions is the same: rather than broadly suppressing the immune system, modern treatments aim to shut down the specific pathways that are misfiring.